Join Rahul and Professor Stephen Nicholls as they pick apart the peculiarities of the Lp(a) particle. Steve wears many hats as a clinical trialist, lipidologist, leader of the Victorian Heart Institute and current president of the Cardiac Society of Australia and New Zealand.

In this podcast, we talk about the structure and function of Lp(a), the evidence supporting Lp(a) as a risk factor for cardiovascular disease, how to approach testing for Lp(a) and finally how to manage someone with a high Lp(a). Steve is an investigator on many of the trials testing new Lp(a) lowering therapies and guides us on how the scene is likely to take shape in the next few years. Don't miss this one!